FDA Inspection 1199398 — Oklahoma Blood Institute Norman Center

Oklahoma Blood Institute Norman Center — FEI 3003949967

The FDA completed an inspection of Oklahoma Blood Institute Norman Center on February 28, 2023 in Norman, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Norman, OK (United States)